{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:25:06Z","timestamp":1782581106259,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"S14","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Influenza A virus is one of the leading causes of annual mortality. The emerging of novel escape variants of the influenza A virus is still a considerable challenge in the annual process of vaccine production. The evolution of vaccines ranks among the most critical successes in medicine and has eradicated numerous infectious diseases. Recently, multi-epitope vaccines, which are based on the selection of epitopes, have been increasingly investigated.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study utilized an immunoinformatic approach to design a recombinant multi-epitope vaccine based on a highly conserved epitope of hemagglutinin, neuraminidase, and membrane matrix proteins with fewer changes or mutate over time. The potential B cells, cytotoxic T lymphocytes (CTL), and CD4 T cell epitopes were identified. The recombinant multi-epitope vaccine was designed using specific linkers and a proper adjuvant. Moreover, some bioinformatics online servers and datasets were used to evaluate the immunogenicity and chemical properties of selected epitopes. In addition, Universal Immune System Simulator (UISS) in silico trial computational framework was run after influenza exposure and recombinant multi-epitope vaccine administration, showing a good immune response in terms of immunoglobulins of class G (IgG), T Helper 1 cells (TH1), epithelial cells (EP) and interferon gamma (IFN-g) levels. Furthermore, after a reverse translation (i.e., convertion of amino acid sequence to nucleotide one) and codon optimization phase, the optimized sequence was placed between the two EcoRV\/MscI restriction sites in the PET32a<jats:sup>+<\/jats:sup> vector.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The proposed \u201cRecombinant multi-epitope vaccine\u201d was predicted with unique and acceptable immunological properties. This recombinant multi-epitope vaccine can be successfully expressed in the prokaryotic system and accepted for immunogenicity studies against the influenza virus at the in silico level. The multi-epitope vaccine was then tested with the Universal Immune System Simulator (UISS) in silico trial platform. It revealed slight immune protection against the influenza virus, shedding the light that a multistep bioinformatics approach including molecular and cellular level is mandatory to avoid inappropriate vaccine efficacy predictions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-022-04581-6","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T12:02:52Z","timestamp":1643803372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["In silico design of recombinant multi-epitope vaccine against influenza A virus"],"prefix":"10.1186","volume":"22","author":[{"given":"Avisa","family":"Maleki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Alessandro","family":"Parasiliti Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"4581_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","volume":"12","author":"ED Kilbourne","year":"2006","unstructured":"Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12:9.","journal-title":"Emerg Infect Dis"},{"key":"4581_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.yexmp.2014.12.005","volume":"98","author":"C Guo","year":"2015","unstructured":"Guo C, Xie X, Li H, Zhao P, Zhao X, Sun J, et al. Prediction of common epitopes on hemagglutinin of the influenza A virus (H1 subtype). Exp Mol Pathol. 2015;98:79\u201384.","journal-title":"Exp Mol Pathol"},{"key":"4581_CR3","doi-asserted-by":"crossref","unstructured":"Hause BM, Collin EA, Liu R, Huang B, Sheng Z, Lu W, et al. Characterization of a novel influenza virus in cattle and swine: proposal for a new genus in the Orthomyxoviridae family. mBio. 2014;5.","DOI":"10.1128\/mBio.00031-14"},{"key":"4581_CR4","doi-asserted-by":"crossref","unstructured":"Widjaja I, de Vries E, Rottier PJM, de Haan CAM. Competition between influenza A virus genome segments. PLoS ONE. 2012;7.","DOI":"10.1371\/journal.pone.0047529"},{"issue":"SUPPL. 4","key":"4581_CR5","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"NM Bouvier","year":"2008","unstructured":"Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26(SUPPL. 4):D49-53.","journal-title":"Vaccine"},{"key":"4581_CR6","doi-asserted-by":"crossref","unstructured":"Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, et al. New world bats harbor diverse influenza A viruses. PLOS Pathogens. 2013;9:e1003657.","DOI":"10.1371\/journal.ppat.1003657"},{"key":"4581_CR7","doi-asserted-by":"crossref","unstructured":"Wu NC, Wilson IA. Structural insights into the design of novel anti-influenza therapies. Nat Struct Mol Biol. 2018;25:2. 2018;25:115\u201321.","DOI":"10.1038\/s41594-018-0025-9"},{"key":"4581_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.micinf.2017.08.010","volume":"19","author":"Y Guo","year":"2017","unstructured":"Guo Y, He L, Song N, Li P, Sun S, Zhao G, et al. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection. Microbes Infect. 2017;19:641\u20137.","journal-title":"Microbes Infect"},{"key":"4581_CR9","unstructured":"K N. [The mechanism of antigenic shift and drift of human influenza virus]. Nihon rinsho Jpn J Clin Med. 2003;61:1897\u2013903."},{"key":"4581_CR10","doi-asserted-by":"crossref","unstructured":"Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature 2015 523:7559. 2015;523:217\u201320.","DOI":"10.1038\/nature14460"},{"key":"4581_CR11","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","volume":"25","author":"F Carrat","year":"2007","unstructured":"Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25:6852\u201362.","journal-title":"Vaccine"},{"key":"4581_CR12","doi-asserted-by":"crossref","unstructured":"KimHyunsuh, G. W, J. W. Influenza virus: dealing with a drifting and shifting pathogen. https:\/\/home.liebertpub.com\/vim. 2018;31:174\u201383.","DOI":"10.1089\/vim.2017.0141"},{"key":"4581_CR13","first-page":"159","volume":"130","author":"C Bianca","year":"2015","unstructured":"Bianca C, Riposo J, Bianca C, Riposo J. Mimic therapeutic actions against keloid by thermostatted kinetic theory methods. EPJP. 2015;130:159.","journal-title":"EPJP"},{"key":"4581_CR14","doi-asserted-by":"crossref","unstructured":"Kanyiri CW, Mark K, Luboobi L. Mathematical analysis of influenza A dynamics in the emergence of drug resistance. Comput Math Methods Med. 2018;2018.","DOI":"10.1155\/2018\/2434560"},{"key":"4581_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18203\/2349-3259.ijct20161408","volume":"3","author":"M Viceconti","year":"2016","unstructured":"Viceconti M, Henney A, Morley-Fletcher E. In silico clinical trials: how computer simulation will transform the biomedical industry. Int J Clin Trials. 2016;3:37.","journal-title":"Int J Clin Trials"},{"key":"4581_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1172\/JCI0215999","volume":"110","author":"P Palese","year":"2002","unstructured":"Palese P, Garc\u00eda-Sastre A. Influenza vaccines: present and future. J Clin Investig. 2002;110:9\u201313.","journal-title":"J Clin Investig"},{"key":"4581_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11262-018-1609-5","volume":"55","author":"B Farahmand","year":"2019","unstructured":"Farahmand B, Taheri N, Shokouhi H, Soleimanjahi H, Fotouhi F. Chimeric protein consisting of 3M2e and HSP as a universal influenza vaccine candidate: from in silico analysis to preliminary evaluation. Virus Genes. 2019;55:22\u201332.","journal-title":"Virus Genes"},{"key":"4581_CR18","doi-asserted-by":"crossref","unstructured":"Ponomarenko J, Bui H-H, Li W, Fusseder N, Bourne PE, Sette A, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 2008;9:1\u20138.","DOI":"10.1186\/1471-2105-9-514"},{"key":"4581_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","volume":"35","author":"A Hampson","year":"2017","unstructured":"Hampson A, Barr I, Cox N, Donis RO, Siddhivinayak H, Jernigan D, et al. Improving the selection and development of influenza vaccine viruses\u2014report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015. Vaccine. 2017;35:1104\u20139.","journal-title":"Vaccine"},{"key":"4581_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1637\/0005-2086-47.s3.828","volume":"47","author":"H Nili","year":"2003","unstructured":"Nili H, Asasi K. Avian influenza (H9N2) outbreak in Iran. Avian Dis. 2003;47:828\u201331.","journal-title":"Avian Dis"},{"key":"4581_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4046\/trd.2016.79.2.70","volume":"79","author":"JY Kim","year":"2016","unstructured":"Kim JY. The 2009 H1N1 pandemic influenza in Korea. Tubercul Respir Dis. 2016;79:70\u20133.","journal-title":"Tubercul Respir Dis"},{"key":"4581_CR22","doi-asserted-by":"crossref","unstructured":"Sajjad R, Ahmad S, Azam SS. In silico screening of antigenic B-cell derived T-cell epitopes and designing of a multi-epitope peptide vaccine for Acinetobacter nosocomialis. J Mol Graph Model. 2020;94:107477.","DOI":"10.1016\/j.jmgm.2019.107477"},{"key":"4581_CR23","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65:1357\u201369.","journal-title":"Adv Drug Deliv Rev"},{"key":"4581_CR24","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1128\/JVI.01861-14","volume":"88","author":"L Steinbruck","year":"2014","unstructured":"Steinbruck L, Klingen TR, McHardy AC. Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol. 2014;88:12123\u201332.","journal-title":"J Virol"},{"key":"4581_CR25","doi-asserted-by":"crossref","unstructured":"Schubert B, Lund O, Nielsen M. Evaluation of peptide selection approaches for epitope-based vaccine design. 2013;82:243\u201351.","DOI":"10.1111\/tan.12199"},{"key":"4581_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nrd2224","volume":"6","author":"AW Purcell","year":"2007","unstructured":"Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007;6:404\u201314.","journal-title":"Nat Rev Drug Discov"},{"key":"4581_CR27","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/bioinformatics\/btw399","volume":"32","author":"QM Sheikh","year":"2016","unstructured":"Sheikh QM, Gatherer D, Reche PA, Flower DR. Towards the knowledge-based design of universal influenza epitope ensemble vaccines. Bioinformatics. 2016;32:3233\u20139.","journal-title":"Bioinformatics"},{"key":"4581_CR28","doi-asserted-by":"crossref","unstructured":"Sun Y, Shi Y, Zhang W, Li Q, Liu D, Vavricka C, et al. In silico characterization of the functional and structural modules of the hemagglutinin protein from the swine-origin influenza virus A (H1N1)-2009. Sci China Life Sci. 2010 53:6. 2010;53:633\u201342.","DOI":"10.1007\/s11427-010-4010-8"},{"key":"4581_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","volume":"33","author":"AF Altenburg","year":"2015","unstructured":"Altenburg AF, Rimmelzwaan GF, de Vries RD. Virus-specific T cells as correlate of (cross-)protective immunity against influenza. Vaccine. 2015;33:500\u20136.","journal-title":"Vaccine"},{"key":"4581_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ympev.2018.01.008","volume":"121","author":"R Dur\u00e3es-Carvalho","year":"2018","unstructured":"Dur\u00e3es-Carvalho R, Salemi M. In-depth phylodynamics, evolutionary analysis and in silico predictions of universal epitopes of Influenza A subtypes and Influenza B viruses. Mol Phylogenet Evol. 2018;121:174\u201382.","journal-title":"Mol Phylogenet Evol"},{"key":"4581_CR31","doi-asserted-by":"crossref","unstructured":"Silva-Arrieta S, Goulder PJR, Brander C. In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction. PLOS Pathogens. 2020;16:e1008607.","DOI":"10.1371\/journal.ppat.1008607"},{"key":"4581_CR32","doi-asserted-by":"crossref","unstructured":"Pruitt KD, Tatusova T, Maglott DR. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucl Acids Res. 2005;33 suppl_1:D501\u20134.","DOI":"10.1093\/nar\/gki025"},{"key":"4581_CR33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ. Jalview Version 2\u2014a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189\u201391.","journal-title":"Bioinformatics"},{"key":"4581_CR34","doi-asserted-by":"crossref","unstructured":"Potocnakova L, Bhide M, Pulzova LB. An introduction to B-cell epitope mapping and in silico epitope prediction. J Immunol Res. 2016;2016.","DOI":"10.1155\/2016\/6760830"},{"key":"4581_CR35","doi-asserted-by":"crossref","unstructured":"Yao B, Zhang L, Liang S, Zhang C. SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity. PLOS ONE. 2012;7:e45152.","DOI":"10.1371\/journal.pone.0045152"},{"key":"4581_CR36","doi-asserted-by":"crossref","unstructured":"Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucl Acids Res. 2017;45:W24\u20139.","DOI":"10.1093\/nar\/gkx346"},{"key":"4581_CR37","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","volume":"171","author":"B Peters","year":"2003","unstructured":"Peters B, Bulik S, Tampe R, van Endert PM, Holzh\u00fctter H-G. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol. 2003;171:1741\u20139.","journal-title":"J Immunol"},{"key":"4581_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-7-351","volume":"7","author":"Z Stanekov\u00e1","year":"2010","unstructured":"Stanekov\u00e1 Z, Vare\u010dkov\u00e1 E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol J. 2010;7:1\u201313.","journal-title":"Virol J."},{"key":"4581_CR39","doi-asserted-by":"crossref","unstructured":"Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinform. 2009;10:1\u201310.","DOI":"10.1186\/1471-2105-10-296"},{"key":"4581_CR40","doi-asserted-by":"crossref","unstructured":"Reveille JD, Bruce GS. MHC Class II and non-MHC genes in the pathogenesis of systemic lupus erythematosus. Systemic Lupus Erythematosus: Fourth Edition. 2004; pp. 109\u201351.","DOI":"10.1016\/B978-012433901-9\/50007-7"},{"key":"4581_CR41","doi-asserted-by":"crossref","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 2007;8:1\u20137.","DOI":"10.1186\/1471-2105-8-4"},{"key":"4581_CR42","doi-asserted-by":"crossref","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v.2\u2014a server for in silico prediction of allergens. J Mol Model. 2014;20:1\u20136.","DOI":"10.1007\/s00894-014-2278-5"},{"key":"4581_CR43","doi-asserted-by":"crossref","unstructured":"Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Consortium OSDD, et al. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE. 2013;8:e73957.","DOI":"10.1371\/journal.pone.0073957"},{"key":"4581_CR44","doi-asserted-by":"crossref","unstructured":"Bui H-H, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform. 2006;7:1\u20135.","DOI":"10.1186\/1471-2105-7-153"},{"key":"4581_CR45","doi-asserted-by":"crossref","unstructured":"Liniger M, Summerfield A, Ruggli N. MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens. PLOS ONE. 2012;7:e49952.","DOI":"10.1371\/journal.pone.0049952"},{"key":"4581_CR46","doi-asserted-by":"crossref","unstructured":"Hongzhou H, Jishu S, Julia L, Ziyan L, McVey DS, Sun XS. Design of a shear-thinning recoverable peptide hydrogel from native sequences and application for influenza H1N1 vaccine adjuvant. Soft Matter. 2011;7:8905\u201312.","DOI":"10.1039\/c1sm05157a"},{"key":"4581_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08842-w","volume":"7","author":"N Khatoon","year":"2017","unstructured":"Khatoon N, Pandey RK, Prajapati VK. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci Rep. 2017;7:1\u201312.","journal-title":"Sci Rep"},{"key":"4581_CR48","doi-asserted-by":"crossref","unstructured":"Dong R, Chu Z, Yu F, Zha Y. Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches. Front Immunol. 2020;0:1784.","DOI":"10.3389\/fimmu.2020.01784"},{"key":"4581_CR49","doi-asserted-by":"publisher","unstructured":"Ayyagari VS, C. VT, K. AP, Srirama K. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach (2020). https:\/\/doi.org\/10.1080\/07391102.2020.1850357","DOI":"10.1080\/07391102.2020.1850357"},{"key":"4581_CR50","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3390\/cells10102744","volume":"10","author":"A Ras-Carmona","year":"2021","unstructured":"Ras-Carmona A, Pelaez-Prestel HF, Lafuente EM, Reche PA. BCEPS: a web server to predict linear B cell epitopes with enhanced immunogenicity and cross-reactivity. Cells. 2021;10:2744.","journal-title":"Cells"},{"key":"4581_CR51","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook. 2005;, pp 571\u2013607.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"4581_CR52","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch M, Carballo-Amador MA, Charonis S, Curtis R, Warwicker J. Protein\u2013Sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 2017;33:3098\u2013100.","journal-title":"Bioinformatics"},{"key":"4581_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics. 2000;16:404\u20135.","journal-title":"Bioinformatics"},{"key":"4581_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Peng J, Ma J, Xu J. Protein secondary structure prediction using deep convolutional neural fields. Sci Rep. 2016;6:1\u201311.","journal-title":"Sci Rep"},{"key":"4581_CR55","doi-asserted-by":"publisher","first-page":"W430","DOI":"10.1093\/nar\/gkw306","volume":"44","author":"S Wang","year":"2016","unstructured":"Wang S, Li W, Liu S, Xu J. RaptorX-property: a web server for protein structure property prediction. Nucl Acids Res. 2016;44:W430\u20135.","journal-title":"Nucl Acids Res"},{"key":"4581_CR56","first-page":"482","volume":"19","author":"Y Yang","year":"2018","unstructured":"Yang Y, Gao J, Wang J, Heffernan R, Hanson J, Paliwal K, et al. Sixty-five years of the long march in protein secondary structure prediction: the final stretch? Brief Bioinform. 2018;19:482\u201394.","journal-title":"Brief Bioinform"},{"key":"4581_CR57","doi-asserted-by":"crossref","unstructured":"Grote A, Hiller K, Scheer M, M\u00fcnch R, N\u00f6rtemann B, Hempel DC, et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucl Acids Res. 2005;33 suppl_2:W526\u201331.","DOI":"10.1093\/nar\/gki376"},{"key":"4581_CR58","unstructured":"pET Bacterial Recombinant Protein Expression Vector | VectorBuilder. https:\/\/en.vectorbuilder.com\/resources\/vector-system\/pET16b.html. Accessed 29 Oct 2021."},{"key":"4581_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11538-016-0225-6","volume":"79","author":"G An","year":"2017","unstructured":"An G, Fitzpatrick BG, Christley S, Federico P, Kanarek A, Neilan RM, et al. Optimization and control of agent-based models in biology: a perspective. Bull Math Biol. 2017;79:63\u201387.","journal-title":"Bull Math Biol"},{"key":"4581_CR60","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/bioinformatics\/btw293","volume":"32","author":"F Pappalardo","year":"2016","unstructured":"Pappalardo F, Fichera E, Paparone N, Lombardo A, Pennisi M, Russo G, et al. A computational model to predict the immune system activation by citrus-derived vaccine adjuvants. Bioinformatics. 2016;32:2672\u201380.","journal-title":"Bioinformatics"},{"key":"4581_CR61","doi-asserted-by":"crossref","unstructured":"Russo G, Pennisi M, Viceconti M, Pappalardo F. In Silico Trial to test COVID-19 candidate vaccines: a case study with UISS platform. 2020.","DOI":"10.1101\/2020.05.06.080630"},{"issue":"Suppl 6","key":"4581_CR62","first-page":"1","volume":"20","author":"M Pennisi","year":"2019","unstructured":"Pennisi M, Russo G, Sgroi G, Bonaccorso A, Parasiliti Palumbo GA, Fichera E, et al. Predicting the artificial immunity induced by RUTI\u00ae vaccine against tuberculosis using universal immune system simulator (UISS). BMC Bioinform. 2019;20(Suppl 6):1\u201310.","journal-title":"BMC Bioinform"},{"key":"4581_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/cells9030586","volume":"9","author":"F Pappalardo","year":"2020","unstructured":"Pappalardo F, Russo G, Pennisi M, Parasiliti Palumbo GA, Sgroi G, Motta S, et al. The potential of computational modeling to predict disease course and treatment response in patients with relapsing multiple sclerosis. Cells. 2020;9:586.","journal-title":"Cells"},{"key":"4581_CR64","doi-asserted-by":"publisher","unstructured":"Bianca C, Br\u00e9zin L. Modeling the antigen recognition by B-cell and T-cell receptors through thermostatted kinetic theory methods (2017).https:\/\/doi.org\/10.1142\/S1793524517500723","DOI":"10.1142\/S1793524517500723"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-04581-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:16:19Z","timestamp":1669310179000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-04581-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":64,"journal-issue":{"issue":"S14","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["4581"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-04581-6","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"16 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"617"}}